1 week Ago By ABMN Staff
Foster & Motley Inc. acquired a new stake in Intuitive Surgical, Inc. ( NASDAQ:ISRG – Free Report ) during the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC).
The fund acquired 466 shares of the medical equipment provider’s stock, valued at approximately $207,000. Several other large investors have also recently made changes to their positions in ISRG. Creekmur Asset Management LLC increased its holdings in shares of Intuitive Surgical by 200.
0% in the first quarter. Creekmur Asset Management LLC now owns 63 shares of the medical equipment provider’s stock worth $25,000 after purchasing an additional 42 shares during the last quarter. Ridgewood Investments LLC bought a new stake in shares of Intuitive Surgical in the second quarter worth about $26,000.
Able Wealth Management LLC bought a new stake in shares of Intuitive Surgical in the fourth quarter worth about $28,000. Delos Wealth Advisors LLC increased its holdings in shares of Intuitive Surgical by 380.0% in the first quarter.
Delos Wealth Advisors LLC now owns 72 shares of the medical equipment provider’s stock worth $29,000 after purchasing an additional 57 shares during the last quarter. Finally, LRI Investments LLC bought a new stake in shares of Intuitive Surgical in the first quarter worth about $30,000. 83.
64% of the stock is owned by institutional investors. Intuitive Surgical Stock Performance Shares of NASDAQ ISRG opened at $471.82 on Friday.
The firm has a market capitalization of $167.35 billion, a price-to-earnings ratio of 85.17, a PEG ratio of 5.
43 and a beta of 1.39. The stock has a 50 day moving average price of $458.
74 and a 200 day moving average price of $418.27. Intuitive Surgical, Inc.
has a 52-week low of $254.85 and a 52-week high of $493.97.
Analysts Set New Price Targets Several equities research analysts have recently issued reports on the company. Stifel Nicolaus lifted their target price on Intuitive Surgical from $430.00 to $475.
00 and gave the stock a “buy” rating in a report on Friday, July 19th. Barclays boosted their price objective on Intuitive Surgical from $430.00 to $490.
00 and gave the stock an “overweight” rating in a research note on Thursday, July 18th. The Goldman Sachs Group assumed coverage on Intuitive Surgical in a research note on Thursday, May 30th. They set a “buy” rating and a $500.
00 price objective on the stock. Morgan Stanley boosted their price objective on Intuitive Surgical from $375.00 to $460.
00 and gave the stock an “equal weight” rating in a research note on Monday, July 15th. Finally, Redburn Atlantic raised Intuitive Surgical from a “neutral” rating to a “buy” rating and boosted their price objective for the stock from $380.00 to $510.
00 in a research note on Friday, August 2nd. Six research analysts have rated the stock with a hold rating and fifteen have assigned a buy rating to the company’s stock. Based on data from MarketBeat.
com, the stock has an average rating of “Moderate Buy” and an average price target of $446.45. Read Our Latest Analysis on ISRG Insider Activity at Intuitive Surgical In related news, Director Amal M.
Johnson sold 2,943 shares of the business’s stock in a transaction that occurred on Thursday, August 1st. The stock was sold at an average price of $443.30, for a total value of $1,304,631.
90. Following the completion of the sale, the director now owns 12,275 shares in the company, valued at $5,441,507.50.
The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website . In other Intuitive Surgical news, Director Amal M. Johnson sold 2,943 shares of the company’s stock in a transaction on Thursday, August 1st.
The stock was sold at an average price of $443.30, for a total transaction of $1,304,631.90.
Following the completion of the sale, the director now owns 12,275 shares in the company, valued at $5,441,507.50. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link .
Also, EVP Robert Desantis sold 239 shares of the company’s stock in a transaction on Monday, June 10th. The stock was sold at an average price of $416.60, for a total value of $99,567.
40. Following the sale, the executive vice president now owns 5,506 shares of the company’s stock, valued at approximately $2,293,799.60.
The disclosure for this sale can be found here . Over the last quarter, insiders sold 51,656 shares of company stock worth $24,700,644. Company insiders own 0.
90% of the company’s stock. Intuitive Surgical Profile ( Free Report ) Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.
Read More Want to see what other hedge funds are holding ISRG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Intuitive Surgical, Inc. ( NASDAQ:ISRG – Free Report ).
Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter ..
